Sanofi names Peter Guenter as senior vice president, Europe
French drug major Sanofi (Euronext: SAN) yesterday announced the appointment of Peter Guenter, as senior vice president, Europe, effective July 15, 2011. He will report to Hanspeter Spek, president, global operations, and will join the Management Committee.
Mr Guenter, who is currently general manager for the multi-country-organization for Germany, Switzerland and Austria, will succeed Belen Garijo, who will leave the group and take a global leadership role in another pharmaceutical company.
Mr Spek said: “The depth of knowledge and experience Peter gained through his previous management roles in Germany and in Europe, as well as his general business acumen make him ideally suited to lead Sanofi’s operations in Europe.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze